Expansion Potential Sunstone Therapies is a leading provider of psychedelic-assisted therapy delivery in medical settings with ongoing clinical trial activity and plans to scale into clinical delivery post-approval. This suggests opportunities to engage in professional services, equipment, training programs, and site network partnerships to support broader rollout and operational scalability.

Clinical Trial Partnerships Strong emphasis on developing and executing clinical trials, including investigator-initiated studies funded by state and grant programs. This creates openings for research collaborations, contract research organization (CRO) services, data management, regulatory consulting, and trial site expansion collaborations with pharmaceutical and biotech partners.

Sustainability of Care Patient-centric model inspired by oncology care focused on multi-faceted, holistic well-being. This approach aligns with opportunities to offer integrated care solutions, digital patient engagement platforms, and outcomes-driven services that resonate with healthcare providers seeking value-based, long-term treatment pathways.

Tech and Operations Robust tech stack (AWS, Salesforce, HubSpot, monday.com, analytics tools) supports scalable, compliant operations and patient management. Potential sales opportunities include health IT integrations, CRM-driven patient journeys, clinical data management tooling, telemedicine or remote monitoring add-ons, and digital platform services for clinic design and cost modeling.

Funding and Revenue Signals Recent grant funding from Reason for Hope and Maryland IIT support indicates access to non-dilutive capital and growth initiatives. This implies opportunities to offer grant-writing support, commercialization strategy, and partnerships around funded studies, as well as services aligned with expanding patient access and payer engagement strategies.